CCM
VAXX

CAAS Capital Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

CAAS Capital Management’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,771
Closed -$94K – 1003
2021
Q4 		$94K Buy
+16,771
New +$173K ﹤0.01% 719

Other funds holding VAXX

PML
Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CAAS Capital Management's VAXX Position: Q1 2022 in Review

CAAS Capital Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q1 2022, closing a stake of 16,771 shares — an estimated $94K sold.

CAAS Capital Management first reported a position in VAXX in Q4 2021 and held it in 1 quarter. The position peaked at $94K in Q4 2021. 12 funds tracked by Wall St. Rank hold VAXX as of Q1 2022.

  • CAAS Capital Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • CAAS Capital Management sold 16,771 Vaxxinity, Inc. Class A Common Stock shares in Q1 2022, an estimated $94K.
  • CAAS Capital Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 1 quarter.
  • CAAS Capital Management's Vaxxinity, Inc. Class A Common Stock position peaked at $94K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q1 2022.

Based on CAAS Capital Management's 13F filing for Q1 2022, filed 13 May 2022.